Young patients with hematologic and lymphatic malignancies have an increased risk of hip and knee arthroplasty

References

• Makela KT, Visuri T, Pulkkinen P, Eskelinen A, Remes V, Virolainen P, et al. Cancer incidence and cause-specific mortality in patients with metal-on-metal hip replacements in finland. Acta Orthop 2014;85:32–8.
   PubMed Web of Science ®Google Scholar
• Wagner P, Olsson H, Ranstam J, Robertsson O, Zheng MH, Lidgren L. Metal-on-metal joint bearings and hematopoetic malignancy. Acta Orthop 2012;83:553–8.
   PubMed Web of Science ®Google Scholar
• Smith AJ, Dieppe P, Porter M, Blom AW. Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: Linkage study between the national joint registry of england and wales and hospital episode statistics. BMJ 2012;344:e2383
   PubMed Web of Science ®Google Scholar
• Sorensen MS, Gregersen KG, Grum-Schwensen T, Hovgaard D, Petersen MM. Patient and implant survival following joint replacement because of metastatic bone disease. Acta Orthop 2013;84:301–6.
   PubMed Web of Science ®Google Scholar
• van Egmond PW, Taminiau AH, van der Heide HJ. Hemiarthroplasties in young patients with osteonecrosis or a tumour of the proximal femur; an observational cohort study. BMC Musculoskelet Disord 2013;14:31
   PubMed Web of Science ®Google Scholar
• Hu MI, Lu H, Gagel RF. Cancer therapies and bone health. Curr Rheumatol Rep 2010;12:177–85.
   PubMedGoogle Scholar
• Mostoufi-Moab S, Halton J. Bone morbidity in childhood leukemia: Epidemiology, mechanisms, diagnosis, and treatment. Curr Osteoporos Rep 2014;12:300–12.
   PubMed Web of Science ®Google Scholar
• Gawade PL, Hudson MM, Kaste SC, Neglia JP, Wasilewski-Masker K, Constine LS, et al. A systematic review of selected musculoskeletal late effects in survivors of childhood cancer. Curr Pediatr Rev 2014;10:249–62.
   PubMedGoogle Scholar
• Kuhlen M, Moldovan A, Krull K, Meisel R, Borkhardt A. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on co-ALL-07-03 trial: A single centre analysis. Klin Padiatr 2014;226:154–60.
   PubMed Web of Science ®Google Scholar
• Salem KH, Brockert AK, Mertens R, Drescher W. Avascular necrosis after chemotherapy for haematological malignancy in childhood. Bone Joint J 2013;95B:1708–13.
   Web of Science ®Google Scholar
• Fossa A, Fiskvik IH, Kolstad A, Lauritzsen GF, Aurlien E, Blystad AK, et al. Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical hodgkin lymphoma: High cure rates but increased risk of aseptic osteonecrosis. Ann Oncol 2012;23:1254–9.
   PubMed Web of Science ®Google Scholar
• Renedo RJ, Sousa MM, Perez SF, Zabalbeascoa JR, Carro LP. Avascular necrosis of the femoral head in patients with hodgkin's disease. Hip Int 2010;20:473–81.
   PubMed Web of Science ®Google Scholar
• Karimova EJ, Rai SN, Howard SC, Neel M, Britton L, Pui CH, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol 2007;25:1525–31.
   PubMed Web of Science ®Google Scholar
• Talamo G, Angtuaco E, Walker RC, Dong L, Miceli MH, Zangari M, et al. Avascular necrosis of femoral and/or humeral heads in multiple myeloma: Results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy. J Clin Oncol 2005;23:5217–23.
   PubMed Web of Science ®Google Scholar
• Niinimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Paakko EL, et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol 2007;25:1498–504.
   PubMed Web of Science ®Google Scholar
• Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003;101:3373–85.
   PubMed Web of Science ®Google Scholar
• Niinimaki T, Harila-Saari A, Niinimaki R. The diagnosis and classification of osteonecrosis in patients with childhood leukemia. Pediatr Blood Cancer 2014; (Epub ahead of print)
   PubMed Web of Science ®Google Scholar
• Niinimaki R, Hansen LM, Niinimaki T, Olsen JH, Pokka T, Sankila R, et al. Incidence of severe osteonecrosis requiring total joint arthroplasty in children and young adults treated for leukemia or lymphoma: A nationwide, register-based study in finland and denmark. J Adolesc Young Adult Oncol 2013;2:138–44.
   PubMed Web of Science ®Google Scholar
• Leskinen J, Eskelinen A, Huhtala H, Paavolainen P, Remes V. The incidence of knee arthroplasty for primary osteoarthritis grows rapidly among baby boomers: A population-based study in finland. Arthritis Rheum 2012;64:423–8.
   PubMed Web of Science ®Google Scholar
• Pakos EE, Paschos NK, Xenakis TA. Long term outcomes of total hip arthroplasty in young patients under 30. Arch Bone Jt Surg 2014;2:157–62.
   PubMedGoogle Scholar
• Socie G, Cahn JY, Carmelo J, Vernant JP, Jouet JP, Ifrah N, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: Analysis of risk factors for 4388 patients by the societe francaise de greffe de moelle (SFGM). Br J Haematol 1997;97:865–70.
   PubMed Web of Science ®Google Scholar
• Gaynon PS, Carrel AL. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol 1999;457:593–605.
   PubMed Web of Science ®Google Scholar
• Arico M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003;88:747–53.
   PubMed Web of Science ®Google Scholar
• Mattano LA, Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the children's cancer group. J Clin Oncol 2000;18:3262–72.
   PubMed Web of Science ®Google Scholar
• Inaba Pui. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 2010;11:1096–106.
   PubMed Web of Science ®Google Scholar
• Dybvik E, Furnes O, Fossa SD, Trovik C, Lie SA. Long-term risk of receiving a total hip replacement in cancer patients. Cancer Epidemiol 2009;33:235–41.
   PubMed Web of Science ®Google Scholar
• Mäkelä K, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg Am 2008;10:2160–70.
   Web of Science ®Google Scholar
• Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365–9.
   PubMed Web of Science ®Google Scholar